AU476000B2 - 2-amino-2', 6'-propionoxylidide and its therapeutically acceptable salts - Google Patents

2-amino-2', 6'-propionoxylidide and its therapeutically acceptable salts

Info

Publication number
AU476000B2
AU476000B2 AU44886/72A AU4488672A AU476000B2 AU 476000 B2 AU476000 B2 AU 476000B2 AU 44886/72 A AU44886/72 A AU 44886/72A AU 4488672 A AU4488672 A AU 4488672A AU 476000 B2 AU476000 B2 AU 476000B2
Authority
AU
Australia
Prior art keywords
propionoxylidide
amino
acceptable salts
therapeutically acceptable
therapeutically
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU44886/72A
Other languages
English (en)
Other versions
AU4488672A (en
Inventor
NICHOL BOYES BENJAMIN RANDALL DUCE EMIL RICHARD SMITH; and EUGENE WILLIAM BYRNES ROBERT
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hassle AB
Original Assignee
Hassle AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hassle AB filed Critical Hassle AB
Publication of AU4488672A publication Critical patent/AU4488672A/en
Application granted granted Critical
Publication of AU476000B2 publication Critical patent/AU476000B2/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AU44886/72A 1971-07-28 1972-07-24 2-amino-2', 6'-propionoxylidide and its therapeutically acceptable salts Expired AU476000B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16703171A 1971-07-28 1971-07-28
USUS167,031 1971-07-28

Publications (2)

Publication Number Publication Date
AU4488672A AU4488672A (en) 1974-01-31
AU476000B2 true AU476000B2 (en) 1976-09-09

Family

ID=22605664

Family Applications (1)

Application Number Title Priority Date Filing Date
AU44886/72A Expired AU476000B2 (en) 1971-07-28 1972-07-24 2-amino-2', 6'-propionoxylidide and its therapeutically acceptable salts

Country Status (23)

Country Link
JP (1) JPS565220B1 (ru)
AR (1) AR193748A1 (ru)
AT (1) AT317185B (ru)
AU (1) AU476000B2 (ru)
BE (1) BE786875A (ru)
BR (1) BR7205069D0 (ru)
CA (1) CA982148A (ru)
CH (1) CH574397A5 (ru)
CS (1) CS171171B2 (ru)
DD (1) DD101389A5 (ru)
DK (1) DK142843B (ru)
ES (1) ES404739A1 (ru)
FI (1) FI55492C (ru)
FR (1) FR2147277B1 (ru)
GB (1) GB1374367A (ru)
HU (1) HU163818B (ru)
IE (1) IE36607B1 (ru)
NL (1) NL176254C (ru)
NO (1) NO137500C (ru)
PL (1) PL84891B1 (ru)
SE (1) SE399702B (ru)
SU (1) SU441704A3 (ru)
ZA (1) ZA724512B (ru)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57182525U (ru) * 1981-05-15 1982-11-19
JPH01128053U (ru) * 1988-02-24 1989-08-31
JP2514855B2 (ja) * 1990-08-08 1996-07-10 キッセイ薬品工業株式会社 光学活性なアラニンアニリド誘導体の酸付加塩
GB2267709A (en) * 1992-06-11 1993-12-15 Merck & Co Inc Novel process for the preparation of alpha-aminoacylanilides
CA3027255C (en) 2009-07-10 2022-06-21 The General Hospital Corporation Permanently charged sodium and calcium channel blockers as anti-inflammatory agents
DE102012210082A1 (de) * 2012-06-15 2013-12-19 Hilti Aktiengesellschaft Werkzeugmaschine und Steuerungsverfahren
JP6833811B2 (ja) 2015-08-03 2021-02-24 プレジデント アンド フェローズ オブ ハーバード カレッジ 荷電イオンチャネル遮断薬及び使用方法
US11377422B2 (en) 2019-03-11 2022-07-05 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US10828287B2 (en) 2019-03-11 2020-11-10 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
AU2020237474A1 (en) 2019-03-11 2021-09-30 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US10780083B1 (en) 2019-03-11 2020-09-22 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
CA3129089A1 (en) 2019-03-11 2020-09-17 Bridget Mccarthy Cole Ester substituted ion channel blockers and methods for use
US10933055B1 (en) 2019-11-06 2021-03-02 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
KR20220123381A (ko) 2019-11-06 2022-09-06 녹시온 테라퓨틱스 인코포레이티드 하전된 이온 채널 차단제 및 사용 방법
EP4118070A4 (en) 2020-03-11 2024-04-10 Nocion Therapeutics, Inc. CHARGED ION CHANNEL BLOCKERS AND METHODS OF USE

Also Published As

Publication number Publication date
NL176254B (nl) 1984-10-16
NL7210418A (ru) 1973-01-30
CA982148A (en) 1976-01-20
NO137500B (no) 1977-11-28
GB1374367A (en) 1974-11-20
IE36607L (en) 1973-01-28
DK142843B (da) 1981-02-09
SE399702B (sv) 1978-02-27
FR2147277B1 (ru) 1976-04-16
JPS565220B1 (ru) 1981-02-04
DK142843C (ru) 1981-08-31
AU4488672A (en) 1974-01-31
IE36607B1 (en) 1976-12-08
DE2235745B2 (de) 1976-08-19
AR193748A1 (es) 1973-05-22
PL84891B1 (en) 1976-04-30
ZA724512B (en) 1973-08-29
NO137500C (no) 1978-03-08
AT317185B (de) 1974-08-12
ES404739A1 (es) 1975-07-16
FI55492B (fi) 1979-04-30
SU441704A3 (ru) 1974-08-30
FR2147277A1 (ru) 1973-03-09
FI55492C (fi) 1979-08-10
CH574397A5 (ru) 1976-04-15
DD101389A5 (ru) 1973-11-05
DE2235745A1 (de) 1973-02-22
CS171171B2 (ru) 1976-10-29
BR7205069D0 (pt) 1973-07-17
HU163818B (ru) 1973-11-28
NL176254C (nl) 1985-03-18
BE786875A (fr) 1973-01-29

Similar Documents

Publication Publication Date Title
AU476000B2 (en) 2-amino-2', 6'-propionoxylidide and its therapeutically acceptable salts
AU465934B2 (en) Preparation of d,d'-2,2'-(ethylenedimino) -di-1-butanol hydrochloride
CA963468A (en) Derives de l'isoquinoleine
CA953107A (en) Panneau d'affichage
CA977758A (en) Exo-2-phenyl-bicyclo-(2,2,1)-heptane-2-(n-methyl-piperidol-4-)-carbonic-acid-ester and salts thereof
CA992079A (en) Optically active 1,4-benzodiazepines and process for the preparation thereof
CA989842A (en) 2-mercapto-pyrido(1,2-6)1,2,4-thiodiazolium salts and derivatives thereof
CA882705A (en) 5,8-dihydronaphthyloxy-amino-propanols and related compounds
CA984386A (en) 2-halo-2',3',5'-tri-0-acylinosines and the production thereof
AU467915B2 (en) 2, 5-substituted thiasiazoles and their preparation
CA885976A (en) N-(d-6-methyl-8-isoergolenyl)-n',n'-diethylcarbamide and physiologically acceptable salts thereof
CA924733A (en) Pseudothioureas and their salts
AU473794B2 (en) 2',3',5'-tri-o-nicotinoyl-4-thiouridine
CA874984A (en) Levo-1-n-butyl-2',6'-pipecoloxylidide
CA863355A (en) 1-n-methyl-(4'-butoxy-2',6'-dimethylbenzoylamino)-methyl-pyridines and pyrrolidines
CA875569A (en) 3,3'-bis-2-pyrazolines
CA874440A (en) 6,1'-spirocyclopropylprogesterones
CA860343A (en) 2-(n'-(o-alkoxyphenyl) piperazinomethyl)-3-quinuclidinone
CA889345A (en) 4'-phenoxyalkanesulfonanilides
CA885439A (en) 3-ethylenedioxy gona-4,9,11-trienes
CA863959A (en) N,n'-alkylene-bis-dibenzobicyclo-octanopyrrolidine compounds and production thereof
CA870627A (en) 1,3,4-thiazolidine-2-thiones and their preparation
CA873352A (en) 1,2,3,4-tetrahydro-isoquinolines and their preparation
AU462250B2 (en) Pharmaceutically active triazenomidazoles
AU455249B2 (en) Manufacature of 1,1'-disubstituted-4,4'-benpyridylium salts and related compounds